PMID: 12778965Jun 5, 2003Paper

Anthrax 2001--lessons learned: clinical laboratory and beyond

Clinical Laboratory Science : Journal of the American Society for Medical Technology
Dyan C Luper

Abstract

Re-visit the 2001 anthrax outbreak to assess the ideas and concepts learned from the event as they relate to the illness and to bioterrorism preparedness. Current literature. A multitude of lessons have been brought to light. The future of bioterrorism preparedness depends on whether those lessons are acknowledged and acted upon.

Related Concepts

Related Feeds

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Related Papers

Journal of Continuing Education in Nursing
Terri Rebmann, Lisa Buettner Mohr
Clinical Laboratory Science : Journal of the American Society for Medical Technology
Cheryl R Caskey
The Journal of Family Practice
Frederick M ChenHelen Burstin
© 2022 Meta ULC. All rights reserved